+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
MARKSANS

Marksans Pharma Share Price

₹307.95 -10.55 (-3.31%)
98.68% Gain from 52W Low

16 Nov, 2026 2:16 PM (IST)

Marksans Pharma live price: ₹307.95. It opened at ₹319 vs previous close ₹319; intraday high/low: ₹319/₹308. The 50 & 200 DMA stand at ₹309.70/₹266.60.

Marksans Pharma Performance

  • Today's Low
  • ₹308
  • Today's High
  • ₹319
  • 52 Week Low
  • ₹155
  • 52 Week High
  • ₹351
  • Open Price₹319
  • Previous Close₹319
  • Volume1,009,078
  • 50 DMA₹309.70
  • 100 DMA₹294.60
  • 200 DMA₹266.60

Marksans Pharma Chart

Investment Returns

  • Over 1 Month + 0.03%
  • Over 3 Month -7.52%
  • Over 6 Month + 48.45%
  • Over 1 Year + 60.02%

Smart Investing Starts Here Start SIP with Marksans Pharma for Steady Growth!

Invest Now

Marksans Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 24.9
  • PEG Ratio
  • 0.4
  • Market Cap Cr
  • 13,957
  • P/B Ratio
  • 4.4
  • Average True Range
  • 12.5
  • EPS
  • 12.4
  • Dividend Yield
  • 0.3
  • MACD Signal
  • -0.3
  • RSI
  • 54.44
  • MFI
  • 56.35

Latest Stock News Updates

Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Transcript of Investors/Analyst meet on Q2 FY27 Financial Results

Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Audio Recording of investor(s)/analyst(s) meet Conference Call on Q2 FY 27 Financial Results

Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Publication for Unaudited Financial Results for the quarter and half year ended September 30, 2026

Marksans Pharma Financials

Marksans Pharma Technicals

EMA & SMA

Current Price
₹307.95
-10.55 (-3.31%)
pointer
  • Bearish Moving Average 10
  • Bullish Moving Average 6
  • 20 Day
  • ₹310.40
  • 50 Day
  • ₹309.70
  • 100 Day
  • ₹294.60
  • 200 Day
  • ₹266.60

Resistance and Support

311.48 Pivot Speed
  • R3 339.50
  • R2 334.10
  • R1 326.30
  • S1 313.10
  • S2 307.70
  • S3 299.90

Marksans Pharma Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-11-04 Quarterly Results
2026-08-12 Quarterly Results
2026-05-26 Audited Results & Final Dividend
2026-02-05 Quarterly Results
2025-11-13 Quarterly Results
Date Purpose Remarks
2026-08-20 FINAL Rs.0.90 per share(90%)Final Dividend
2025-08-01 FINAL Rs.0.80 per share(80%)Final Dividend
2024-09-17 FINAL Rs.0.60 per share(60%)Final Dividend
2023-06-07 FINAL Rs.0.50 per share(50%)Final Dividend
View Marksans Pharma Dividend History Arrow

Marksans Pharma Shareholding Pattern

43.87%
31.53%
19.06%
3.72%
1.82%

About Marksans Pharma

Marksans Pharma engaged in the business of research, manufacture, marketing and selling pharmaceutical formulations. It operates two manufacturing facilities in Goa and maintains two R&D centers; one located in Goa and the other in Navi Mumbai, Maharashtra. View More
  • NSE Symbol
  • MARKSANS
  • BSE Symbol
  • 524404
  • Managing Director(Operations)
  • Mr. Sathish Kumar
  • ISIN
  • INE750C01026

Similar Stocks to Marksans Pharma

Marksans Pharma FAQs

Marksans Pharma share price is ₹307 As on 16 November, 2026 | 14:07

The Market Cap of Marksans Pharma is ₹13956.9 Cr As on 16 November, 2026 | 14:07

The P/E ratio of Marksans Pharma is 24.9 As on 16 November, 2026 | 14:07

The PB ratio of Marksans Pharma is 4.4 As on 16 November, 2026 | 14:07

The 52 week High & Low of Marksans Pharma is ₹351/₹155 respectively As on 16 November, 2026 | 14:07

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23